$445.88▼ 5.75 (1.27%)
Real-time prices · US MarketsHigh-quality business with 18% return on equity and 26% profit margins.
Quality
8.5
Health
7.2
Growth
6.5
Valuation
6
Sentiment
7.8
Analyst Target
$482.63
▲ +8.2% from current
Price Chart
Latest News
Fundamentals
Trailing P/E
53.9×
price-to-earnings
Forward P/E
35.8×
next 12 months est.
Market Cap
$157.5B
market capitalization
Div Yield
0.00%
dividend yield
Profit Margin
25.5%
net profit margin
Gross Margin
66.6%
revenue minus COGS
ROE
17.9%
return on equity
Beta
1.46
vs S&P 500
52-Week Range
$329 — $604
annual min — max
EPS — Estimate vs Actual
Frequently Asked Questions
What do analysts say about Intuitive Surgical, Inc. right now?
Intuitive Surgical, Inc.'s Q·Score is 7.2/10 (Bullish), reflecting its current fundamentals, analyst data, and valuation metrics. High-quality business with 18% return on equity and 26% profit margins. This is an informational data summary only and does not constitute financial advice. Always do your own research before making any investment decision.
What is the analyst price target for ISRG?
The consensus price target for ISRG is $482.63, based on ratings from 30 Wall Street analysts. This is 8.2% above the current price of $445.88. Price targets are forward-looking estimates and not guarantees of future performance.
Is ISRG overvalued or undervalued?
Intuitive Surgical, Inc. (ISRG) scores in line with sector averages on valuation metrics. Its forward P/E ratio stands at 35.8×. The consensus analyst price target of $482.63 is 8% above the current price.
When does Intuitive Surgical, Inc. report its next earnings?
Intuitive Surgical, Inc.'s next earnings report is expected on approximately January 21, 2027.
What is Intuitive Surgical, Inc.'s profit margin?
Intuitive Surgical, Inc. has a net profit margin of 25.5%, which is considered high and reflects strong pricing power. Its gross margin stands at 66.6%, indicating a high-margin business model.
Is Intuitive Surgical, Inc.'s revenue growing?
Intuitive Surgical, Inc. is reporting strong year-over-year growth of 21.7%. However, earnings declined 23.6%, which warrants monitoring.
Compare ISRG with any stock